BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 18653785)

  • 1. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.
    Hartmann TN; Grabovsky V; Pasvolsky R; Shulman Z; Buss EC; Spiegel A; Nagler A; Lapidot T; Thelen M; Alon R
    J Leukoc Biol; 2008 Oct; 84(4):1130-40. PubMed ID: 18653785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands.
    Zabel BA; Wang Y; Lewén S; Berahovich RD; Penfold ME; Zhang P; Powers J; Summers BC; Miao Z; Zhao B; Jalili A; Janowska-Wieczorek A; Jaen JC; Schall TJ
    J Immunol; 2009 Sep; 183(5):3204-11. PubMed ID: 19641136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12 enhances human neural progenitor cell survival through a CXCR7- and CXCR4-mediated endocytotic signaling pathway.
    Zhu B; Xu D; Deng X; Chen Q; Huang Y; Peng H; Li Y; Jia B; Thoreson WB; Ding W; Ding J; Zhao L; Wang Y; Wavrin KL; Duan S; Zheng J
    Stem Cells; 2012 Nov; 30(11):2571-83. PubMed ID: 22987307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR4 but not CXCR7 is mainly implicated in ocular leukocyte trafficking during ovalbumin-induced acute uveitis.
    Zhang Z; Zhong W; Hall MJ; Kurre P; Spencer D; Skinner A; O'Neill S; Xia Z; Rosenbaum JT
    Exp Eye Res; 2009 Oct; 89(4):522-31. PubMed ID: 19524567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.
    Levoye A; Balabanian K; Baleux F; Bachelerie F; Lagane B
    Blood; 2009 Jun; 113(24):6085-93. PubMed ID: 19380869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine receptor CXCR7 mediates human endothelial progenitor cells survival, angiogenesis, but not proliferation.
    Yan X; Cai S; Xiong X; Sun W; Dai X; Chen S; Ye Q; Song Z; Jiang Q; Xu Z
    J Cell Biochem; 2012 Apr; 113(4):1437-46. PubMed ID: 22173725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Design Targeting the CXCR4/CXCR7/CXCL12 Pathway.
    Xu D; Li R; Wu J; Jiang L; Zhong HA
    Curr Top Med Chem; 2016; 16(13):1441-51. PubMed ID: 26369824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro.
    Li Q; Zhang A; Tao C; Li X; Jin P
    Biochem Biophys Res Commun; 2013 Nov; 441(3):675-80. PubMed ID: 24184476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
    Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
    Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrullination of CXCL12 differentially reduces CXCR4 and CXCR7 binding with loss of inflammatory and anti-HIV-1 activity via CXCR4.
    Struyf S; Noppen S; Loos T; Mortier A; Gouwy M; Verbeke H; Huskens D; Luangsay S; Parmentier M; Geboes K; Schols D; Van Damme J; Proost P
    J Immunol; 2009 Jan; 182(1):666-74. PubMed ID: 19109200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR7, CXCR4 and CXCL12: an eccentric trio?
    Thelen M; Thelen S
    J Neuroimmunol; 2008 Jul; 198(1-2):9-13. PubMed ID: 18533280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7.
    Zheng J; Wang H; Zhou W
    Reprod Biol Endocrinol; 2018 Mar; 16(1):17. PubMed ID: 29499763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR7 participates in CXCL12-induced CD34+ cell cycling through β-arrestin-dependent Akt activation.
    Torossian F; Anginot A; Chabanon A; Clay D; Guerton B; Desterke C; Boutin L; Marullo S; Scott MG; Lataillade JJ; Le Bousse-Kerdilès MC
    Blood; 2014 Jan; 123(2):191-202. PubMed ID: 24277075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease.
    Werner L; Elad H; Brazowski E; Tulchinsky H; Vigodman S; Kopylov U; Halpern Z; Guzner-Gur H; Dotan I
    J Leukoc Biol; 2011 Sep; 90(3):583-90. PubMed ID: 21628333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo.
    Meijer J; Ogink J; Roos E
    Br J Cancer; 2008 Nov; 99(9):1493-501. PubMed ID: 18854833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.